Cross-sectional CT images showing a metastatic tumor in the left lung of a patient (top image) and no tumor following treatment (bottom image). Credit: NCI Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health (NIH) genetically engineered normal white blood cells, known as lymphocytes, from each patient to produce receptors that recognize and attack their specific cancer cells. These initial findings are from people with metastatic Read More